Helius Raises $500M for Solana Treasury Venture
Helius pivots to crypto, raising $500M for Solana treasury operations led by Pantera Capital.

- Helius shifts from biotech to Solana treasury operations.
- Raises $500M in PIPE to fund the pivot.
- Leadership changes accompany strategic crypto focus.
Helius Medical Technologies (Nasdaq: HSDT) raised over $500 million in a PIPE, led by Pantera Capital and Summer Capital, to establish a publicly traded Solana treasury company confirmed in September 2025.
The strategic shift signifies a departure from biotech, impacting Solana markets and heralding a notable trend in digital asset treasury with a focus on Solana as the primary reserve.
Helius Medical Technologies, trading on Nasdaq, announced a bold shift from its biotech origins to a digital asset treasury focus, centered on Solana (SOL). This pivot is supported by a substantial $500M PIPE deal, unveiled in September 2025. Pantera-backed Helius raises $500M, Solana’s stock surges over 200%.
Pantera Capital and Summer Capital lead this investment, bringing aboard experienced investors like Animoca Brands and FalconX. Helius integrates Joseph Chee as Executive Chairman, supported by Pantera’s Dan Morehead, steering this strategic shift.
The funding injection could significantly influence Solana’s position as a major reserve asset in Helius’s new strategy. With a stake in Solana, the company eyes staking and DeFi opportunities, promising a potential yield return of around 7%.
Analysts speculate that Helius’s Solana investment might trigger broader market reactions, despite Solana’s recent slight value decrease of 4%. Helius’s stocks, however, saw a more than 200% surge, indicating strong market confidence in the crypto move.
A future with reinforced Solana presence in treasury operations appears probable, paralleling MicroStrategy’s BTC strategy. The innovation may create ripples across digital markets, altering treasury strategies among public companies, especially with Solana’s potential staking returns.
Joseph Chee, Director and Executive Chairman, Helius Medical Technologies, – ‘We are excited about this strategic pivot towards digital asset treasury operations focusing on Solana.’
Solana’s focus by Helius might encourage greater integration of blockchain solutions in corporate treasuries, with potential implications for network traffic and utility. Backing from heavyweight investors like Pantera could bolster the sector’s growth trajectory. Official U.S. Securities and Exchange Commission (SEC) website
More From Crypto News
US Spot Bitcoin ETFs See $148.7M Outflow, Ending 9-Day Inflow Run
US spot Bitcoin ETFs posted a net outflow of $148. 7 million, snapping a nine-day inflow streak that had drawn sustained institutional attention to the Bitcoin...
Evernorth Clears Key Armada Merger Vote With $473M Treasury
Evernorth, an XRP-focused treasury company, has cleared a key shareholder vote advancing its proposed merger with Armada Acquisition Corp, a move designed to br...
Ethereum Validator Exit Queue Hits 773,447 ETH as Wait Tops 13 Days
Ethereum’s validator exit queue has climbed to 773,447 ETH, pushing the estimated wait time for a full withdrawal above 13 days. The backlog signals a notable u...
Senate Tax Draft Targets Stablecoin Purchase Gain Recognition
A Senate tax draft circulated by Finance Committee Chairman Mike Crapo would exempt qualifying stablecoin purchases from gain-or-loss recognition, according to...
Ethereum’s Glamsterdam Upgrade Heads to Sepolia Oct. 6
Ethereum’s Glamsterdam upgrade is scheduled to deploy on the Sepolia testnet on October 6, marking the next formal checkpoint in the upgrade’s path toward event...
MetaMask Security Incident: Validator Exits Begin
MetaMask confirmed on September 30, 2026 that it is responding to an ongoing security incident affecting part of its infrastructure, and said it has begun proac...